Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiuwei Shufeng Pingchuan Granules in Chronic Persistent Bronchial Asthma (Wind Wheezing Pattern)
CTR20231108Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Apr 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Jiuwei Shufeng Pingchuan Granules with Placebo (Jiuwei Shufeng Pingchuan Granules mimic) (2 arms). Primary endpoints: Adverse events and adverse drug reactions and Rate of well-controlled asthma. Started Apr 2023; status: completed.
02
Drugs
Jiuwei Shufeng Pingchuan
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20231108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231108.